Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

12/04/2024 07:00

Apr 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 29, 2024        Feb 28, 2023     May 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            715.31              606.30           916.00    
                 (+18.0 pct)         (+8.5 pct)       (+10.7 pct) 
  Operating         23.74               22.17            30.20    
                 (+7.1 pct)          (+1.2 pct)       (+0.2 pct)  
  Recurring         25.91               24.39            33.20    
                 (+6.2 pct)          (+1.2 pct)       (+0.3 pct)  
  Net               17.36               16.28            23.80    
                 (+6.6 pct)          (-1.0 pct)       (+0.0 pct)  
  EPS            438.14 yen          411.22 yen       601.03 yen  
  Ann Div                            100.00 yen       120.00 yen  
  -Q2 div         60.00 yen           42.50 yen                   
  -Q4 div                             57.50 yen        60.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T